Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion type Assertion NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_head.
- NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_provenance.
- NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion evidence source_evidence_literature NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_provenance.
- NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion SIO_000772 7571088 NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_provenance.
- NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion wasDerivedFrom befree-2016 NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_provenance.
- NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_assertion wasGeneratedBy ECO_0000203 NP1312950.RAbEQ3oIs-MG0XemaPekV2qGoEwHDfp81PZ1Bw8Xpdv_w130_provenance.